We want to empower people to live life to the fullest.

Stock exchange releases

• 1/15/2025 Inside information: Orion upgrades full-year outlook for 2024 and provides preliminary information on financial performance for 2024
• 1/15/2025 Recommendation by the Orion Nomination Committee on the proposals to be submitted to the 2025 Annual General Meeting
• 1/13/2025 79,345 Orion Corporation A shares converted into B shares
• 12/19/2024 CORRECTION: Change in Orion Group Executive Management Board as of 1 June 2025 – Mikko Kemppainen appointed General Counsel

All releases 

Press releases

• 1/7/2025 Orion’s collaboration partner Bayer submits application in China for third indication of darolutamide
• 12/30/2024 Orion and Marinus terminate agreement for ganaxolone in Europe
• 12/18/2024 Orion and Abilita Therapeutics announce research collaboration and option to license agreement to develop innovative antibody therapeutics
• 11/22/2024 Orion Research Foundation grants EUR 1,109,000 for research in 2025

All releases 